The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
Open accessAbstract
Hepatitis C virus (HCV) infection is causally associated with insulin resistance and diabetes mellitus. This population-based cohort study aimed to investigate whether antiviral therapy for HCV infection was associated with improved clinical outcomes related to diabetes. From the Taiwan National Health Insurance Research Database, 2,267,270 Taiwanese residents diagnosed with diabetes mellitus were screened for eligibility. HCV infection was defined by a specific diagnosis code and measurement of serum antibody. After excluding patients with serious comorbidity, we enrolled a total of 1,411 eligible patients who received pegylated interferon plus ribavirin (treated cohort), and matched them 1:1 with 1,411 untreated controls by propensity scores (untreated cohort). We also matched the treated cohort 1:4 with 5,644 diabetic patients without HCV infection (uninfected cohort). Participants were followed up for the occurrence of endstage renal disease (ESRD), ischemic stroke, and acute coronary syndrome (ACS) after receiving antiviral treatment or the corresponding calendar date. From 2003 to 2011, the 8-year cumulative incidences of ESRD in the treated, untreated, and uninfected cohorts were 1.1% (95% confidence interval [CI], 0.3-2.0%), 9.3% (95% CI, 5.9-12.7%), and 3.3% (95% CI, 2.3-4.3%), respectively ( P < 0.001); those of stroke were 3.1% (95% CI, 1.1-5.0%), 5.3% (95% CI, 3.0-7.5%), and 6.1% (95% CI, 4.8-7.4%), respectively ( P = 0.01); and those for ACS were 4.1% (95% CI, 2.1-6.1%), 6.6% (95% CI, 3.7-9.5%), and 7.4% (95% CI, 5.9-9.0%), respectively ( P = 0.05). As compared with the untreated cohort, antiviral treatment was associated with multivariate-adjusted hazard ratios of 0.16 (95% CI, 0.07-0.33%) for ESRD, 0.53 (95% CI, 0.30-0.93) for ischemic stroke, and 0.64 (95% CI, 0.39-1.06) for ACS. Conclusion : Antiviral treatment for HCV infection is associated with improved renal and cardiovascular outcomes in diabetic patients. (HEPATOLOGY 2014;59:1293-1302)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Self-citationGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 879
Wu, C.-Y., Chen, Y.-J., Ho, H. J., Hsu, Y.-C., Kuo, K. N., Wu, M.-S., & Lin, J.-T. (2012) · JAMA · doi:10.1001/2012.jama.11975 · Cited by 818
Self-citationShintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Moucari, R., Asselah, T., Cazals–Hatem, D., Voitot, H., Boyer, N., Ripault, M., Sobesky, R., Martinot–Peignoux, M., Maylin, S., Nicolas–Chanoine, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.010 · Cited by 546
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.012 · Cited by 340
Yu, M., Dai, C., Huang, J., Hou, N., Lee, L.-P., Hsieh, M., Chiu, C.-F., Lin, Z.-Y., Chen, S., Hsieh, M., et al. (2006) · Gut · doi:10.1136/gut.2006.102558 · Cited by 286
Veldt, B. J., Chen, W., Heathcote, J. E., Wedemeyer, H., Reichen, J., Hofmann, P. W., de Knegt, R. J., Zeuzem, S., Manns, M. P., Hansen, B. E., et al. (2008) · Hepatology · doi:10.1002/hep.22251 · Cited by 284
Ishizaka, N., Ishizaka, Y., Takahashi, E., Tooda, E.-I., Hashimoto, H., Nagai, R., & Yamakado, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07339-7 · Cited by 283
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†
Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., et al. (2009) · Hepatology · doi:10.1002/hep.22703 · Cited by 265
Hepatitis C virus infection: Molecular pathways to metabolic syndrome
Sheikh, M. Y., Choi, J., Qadri, I., Friedman, J. E., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22269 · Cited by 240
APASL consensus statements and management algorithms for hepatitis C virus infection
Omata, M., Kanda, T., Yu, M.-L., Yokosuka, O., Lim, S.-G., Jafri, W., Tateishi, R., Hamid, S. S., Chuang, W.-L., Chutaputti, A., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9342-y · Cited by 165
Vanni, E., Abate, M. L., Gentilcore, E., Hickman, I., Gambino, R., Cassader, M., Smedile, A., Ferrannini, E., Rizzetto, M., Marchesini, G., et al. (2009) · Hepatology · doi:10.1002/hep.23031 · Cited by 158
Wu, C., Wu, M., Kuo, K. N., Wang, C., Chen, Y., & Lin, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0695 · Cited by 132
Self-citationHuang, J., Dai, C., Hwang, S., Ho, C., Hsiao, P., Hsieh, M., Lee, L., Lin, Z., Chen, S., Hsieh, M., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01181.x · Cited by 127
Simó, R., Lecube, A., Genescà, J., Esteban, J. I., & Hernández, C. (2006) · Diabetes Care · doi:10.2337/dc06-0456 · Cited by 119
Hsu, Y., Lin, J., Chen, T.-T., et al. (2012) · Hepatology · doi:10.1002/hep.25684 · Cited by 70
Self-citationConjeevaram, H. S., Wahed, A. S., Afdhal, N. H., Howell, C. D., Everhart, J. E., & Hoofnagle, J. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.002 · Cited by 68
Cited by
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Petta, S., Maida, M., Macaluso, F. S., Barbara, M., Licata, A., Craxì, A., & Cammà, C. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.09.007 · Cited by 254
Metadata
- Authors
- Hsu, Y.-C., Lin, J.-T., Ho, H. J., Kao, Y.-H., Huang, Y.-T., Hsiao, N.-W., Wu, M.-S., Liu, Y.-Y., & Wu, C.-Y.
- Venue
- Hepatology
- Published
- 2014-04
- Volume
- 59
- Issue
- 4
- Pages
- 1293-1302
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2044349000
- Cited by
- 277
- References
- 28
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
